January 24, 2023
UC San Diego Health’s gastroenterology endoscopy program has been recognized as a leader in quality and safety by the American Society for Gastrointestinal Endoscopy (ASGE), the leading national gastrointestinal endoscopy medical society.
June 13, 2023
Loomba will lead the division at UC San Diego School of Medicine, building upon a team that shines a light on UC San Diego Health’s tripartite mission.
December 8, 2014
Thomas Savides, MD has been named as the first Chief Experience Officer at UC San Diego Health System. In the newly created role, Savides will be responsible for the strategy, leadership and implementation of the plan to improve the total health care experience of patients, families, providers and staff.
September 22, 2022
UC San Diego named John M. Carethers as the vice chancellor for Health Sciences, effective January 1, 2023. Carethers will report directly to the chancellor and is part of the leadership team. He replaces David A. Brenner as vice chancellor for Health Sciences, who stepped down on July 1, 2022.
August 24, 2011
Inflammatory bowel disease (IBD), which affects more than 1 million patients in North America, results from an uncontrolled immune response triggered by environmental factors, such as bacteria, in people genetically predisposed to the disorder. Ulcerative colitis, or inflammation of the lining of the colon, is one such condition.
October 28, 2020
U.S. News & World Report named University of California San Diego School of Medicine a top global university and ranked the divisions of Gastroenterology and Hepatology #1 in the world for research.
August 23, 2023
$9 million grant awarded to researchers with UC San Diego School of Medicine supports new study of semaglutide for liver disease.
August 15, 2012
An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the August 16, 2012 issue of the New…
May 4, 2016
Researchers at University of California San Diego School of Medicine have shown that ozanimod (RPC1063), a novel drug molecule, is moderately effective in the treatment of ulcerative colitis. Results of the Phase II clinical trial will appear in the May 5 issue of the New England Journal of Medicine.
August 24, 2011
Patients in Nevada seeking care for liver disease may now access the university-level expertise of UC San Diego Health System’s Center for Hepatobiliary Disease and Abdominal Transplantation (CHAT).
